Montelukast as a Rescue and Premedication for Rituximab Infusion Reactions

被引：0
|
作者：
Amatto, Lindsay [1 ]
Yacyshyn, Elaine [2 ]
机构：
[1] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada
[2] Univ Alberta, Univ Alberta Hosp, Div Rheumatol, Edmonton, AB T6G 2R3, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2024年 / 51卷 / 08期
关键词：
D O I：
10.3899/jrheum.2024-0116
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：837 / 837
页数：1
相关论文
共 50 条
  • [1] Premedication with montelukast and rupatadine decreased rituximab infusion time, rate, severity of reactions and use of rescue medications
    Kotchetkov, Rouslan
    McLean, Jesse
    Nay, Derek
    Gerard, Lauren
    Hopkins, Sean
    Didiodato, Giulio
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (07) : 1979 - 1986
  • [2] Montelukast-Based Premedication Regimen for Recurrent Cetuximab Infusion-Related Reactions
    Sion, Amy M.
    Milburn, Lyndsey
    Kaczmar, John M.
    JCO ONCOLOGY PRACTICE, 2021, 17 (01) : 54 - +
  • [3] Premedication with montelukast reduces local reactions of allergen immunotherapy
    Wohrl, S.
    Hemmer, W.
    Heinze, G.
    Stingl, G.
    Kinaciyan, T.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S31 - S31
  • [4] Premedication with montelukast reduces local reactions of allergen immunotherapy
    Woehrl, Stefan
    Gamper, Simon
    Hemmer, Wolfgang
    Heinze, Georg
    Stingl, Georg
    Kinaciyan, Tamar
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2007, 144 (02) : 137 - 142
  • [5] Effect of montelukast and rupatadine on rituximab infusion time, rate, severity of reactions, and cost of administration.
    Kotchetkov, Rouslan
    McLean, Jesse
    Gerard, Lauren
    Nay, Derek
    Hopkins, Sean P.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] Oral Glucocorticoid Premedication Is at Least as Effective as Intravenous Glucocorticoid Premedication for Prevention of Infusion-related Reactions to Rituximab in Rheumatoid Arthritis Patients
    Bovens, Pauline
    Van Esveld, Luuk
    Wientjes, Maike
    van Herwaarden, Noortje
    Ten Cate, David
    Melis, Eward
    Lesuis, Nienke
    van den Bemt, Bart
    den Broeder, Alfons
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1085 - 1087
  • [7] INCIDENCE OF INFLIXIMAB (IFX) INFUSION REACTIONS WITH AND WITHOUT PREMEDICATION
    Bartoli, F.
    Fiori, G.
    Galluccio, F.
    Nacci, F.
    Salvadorini, G.
    Cerinic, M. Matucci
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 229 - 230
  • [8] Evaluation of Montelukast for the Prevention of Infusion-related Reactions With Daratumumab
    Moore, Donald C.
    Arnall, Justin R.
    Thompson, Daniel L.
    Martin, Allison L.
    Robinson, Jordan
    Ndiaye, Ami
    Paul, Barry
    Atrash, Shebli
    Bhutani, Manisha
    Voorhees, Peter M.
    Usmani, Saad Z.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (10): : E777 - E781
  • [9] Tolerance induction in patients with infusion reactions to rituximab
    Mhanna, H.
    Jukic, K.
    Enriquez, A.
    Vives, R.
    Jimenez, A.
    Almonte, P.
    ALLERGY, 2011, 66 : 379 - 379
  • [10] Cetuximab, rituximab infusion reactions increase costs
    Reactions Weekly, 2009, 1242 (1) : 3 - 3
12345